Ali Murat Kahveci and Veysel Tahan, “Daclatasvir plus sofosbuvir regimen sheds promising light on future hepatitis C virus genotype 3 therapies ”, Turkish Journal of Gastroenterology, vol. 27, no. 1, pp. 89–90, Jul. 2019.